NCT02561273 2023-12-13Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's LymphomaUniversity of NebraskaPhase 1/2 Completed54 enrolled 14 charts